AgeX Therapeutics (AGE US): Synthetic Expert Call Transcript (27 Aug 2026)
POZ platform's structural advantage over PEGylation lies in its tertiary amide backbone, which resists oxidation, and its high-density pendant...
86 Views
IPO Databook: Serina Therapeutics (SER US) - Aug 2026
Serina Therapeutics, Inc. is a clinical-stage biotechnology company developing wholly-owned drug product candidates for neurological diseases. Its...
87 Views
Today's Dominant Ideas
Technically, the SET Index is expected to move sideways up, with the resistance at 1,431 points/1,440 points (50-day EMA) and the support at...
92 Views
Market Outlook
The SET Index is expected to move sideways down, with the resistance at 1,650/1,660 points and the support at 1,620/1,610 points. Technically, the...
90 Views
Technical Analysis
The SET Index is expected to move up, with the support at 1,615/1,610 points and the resistance at 1,635/1,640 points, in response to the report...
91 Views